Found 6702 matches for
Vaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured £20 million in Series A financing.
The Kennedy Trust for Rheumatology Research-funded OxKen programme will fully fund 4 medical students each year from 2021-5 to undertake DPhils in the Medical Sciences Division in the fields of musculoskeletal disease, inflammation and immunology.
The DPhil in Computational Discovery is a multidisciplinary programme spanning projects in Advanced Molecular Simulations, Machine Learning and Quantum Computing to develop new tools and methodologies for life sciences discovery.
The DPhil in Cancer Science programme is unique and distinctive in offering integrated training across the following themes: Immunity, Infection & Inflammation; DNA Damage Response & Radiation Biology; Cancer Genetics & Epigenetics; and Cancer Big Data. It builds on Oxford’s outstanding research record in these areas, spanning both the University and Hospital Trust.